Literature DB >> 28535403

The predictive effect of inflammatory markers and lipid accumulation product index on clinical symptoms associated with polycystic ovary syndrome in nonobese adolescents and younger aged women.

Esra Nur Tola1, Serenat Eris Yalcin2, Nadiye Dugan3.   

Abstract

OBJECTIVE(S): The aim of our study is to analyse the inflammatory markers and lipid accumulation product (LAP) index in nonobese adolescents and younger aged women with polycystic ovary syndrome (PCOS) compared with age and body mass index (BMI)-matched healthy controls and to determine whether the investigated parameters are potential markers for the etiopathogenesis of PCOS. We also aim to determine whether these inflammatory markers are predictive for developing some clinical implications, such as cardiovascular disease (CVD) and insulin resistance (IR), associated with PCOS. STUDY
DESIGN: A total of 34 adolescents and younger aged females with PCOS, and 33 age and BMI-matched healthy controls were recruited for our study. All participants were nonobese (BMI<25). Neopterin (NEO), C-reactive protein (CRP) levels and complete blood parameters were assessed. LAP index and homeostasis model assessment of IR (HOMA-IR) were calculated; anthropometric, clinical and biochemical parameters were also recorded.
RESULTS: Serum NEO, CRP levels and LAP index were significantly increased in nonobese adolescents and younger aged females with PCOS compared to healthy controls. We could not found any predictive effect of investigated inflammatory markers and LAP index on CVD risk among PCOS patients after adjustment for abdominal obesity. We also found a positive predictive effect of WBC and a negative predictive effect of lymphocytes on IR in PCOS patients after adjustment for abdominal obesity. We did not find any predictor effect of NEO on IR, but it was a positive predictive marker for an elevated HOMA-IR index. CONCLUSION(S): Elevated NEO, CRP levels and LAP index could have potential roles in the etiopathogenesis of PCOS in nonobese adolescents and younger aged females,NEO could be a predictive marker for elevated HOMA-IR index, and WBC and lymphocytes could be predictive for the development of IR among nonobese adolescents and younger aged females with PCOS.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Adolescent; Cardiovascular disease; Inflammatory markers; Insulin resistance; Polycystic ovary syndrome

Mesh:

Substances:

Year:  2017        PMID: 28535403     DOI: 10.1016/j.ejogrb.2017.05.014

Source DB:  PubMed          Journal:  Eur J Obstet Gynecol Reprod Biol        ISSN: 0301-2115            Impact factor:   2.435


  6 in total

1.  The effect of metformin treatment on leukocyte telomere length in patients with polycystic ovary syndrome: a prospective case-control study.

Authors:  Özlem Kayacık Günday; Müjgan Özdemir Erdoğan; Ayşen Pehlivan; Mehmet Yılmazer
Journal:  J Assist Reprod Genet       Date:  2022-07-21       Impact factor: 3.357

2.  Lipid accumulation product is a predictor of nonalcoholic fatty liver disease in childhood obesity.

Authors:  Bahar Özcabı; Salih Demirhan; Mesut Akyol; Hatice Öztürkmen Akay; Ayla Güven
Journal:  Korean J Pediatr       Date:  2019-10-28

3.  Peripheral hematological parameters in women with polycystic ovary syndrome.

Authors:  Nadiah A ALhabardi; Osama Al-Wutayd; Khalid M Eltayieb; Yasir S Shiha; Ahmad I Al-Shafei; Ishag Adam
Journal:  J Int Med Res       Date:  2020-09       Impact factor: 1.671

4.  Lipid ratios and obesity indices are effective predictors of metabolic syndrome in women with polycystic ovary syndrome.

Authors:  Małgorzata Kałużna; Magdalena Czlapka-Matyasik; Pola Kompf; Jerzy Moczko; Katarzyna Wachowiak-Ochmańska; Adam Janicki; Karolina Samarzewska; Marek Ruchała; Katarzyna Ziemnicka
Journal:  Ther Adv Endocrinol Metab       Date:  2022-01-10       Impact factor: 3.565

5.  Association between neutrophil-to-lymphocyte ratio and polycystic ovary syndrome: A PRISMA-compliant systematic review and meta-analysis.

Authors:  Li Li; Jianxiu Yu; Zhongwei Zhou
Journal:  Medicine (Baltimore)       Date:  2022-09-23       Impact factor: 1.817

6.  Inflammatory Markers in Women with Polycystic Ovary Syndrome.

Authors:  E Rudnicka; M Kunicki; K Suchta; P Machura; M Grymowicz; R Smolarczyk
Journal:  Biomed Res Int       Date:  2020-03-04       Impact factor: 3.411

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.